Aeluma, Inc. (ALMU) is a Goleta, California-based semiconductor company developing compound-semiconductor photonic and electronic technology—high-speed photodetectors and quantum dot lasers—grown on large-diameter silicon and gallium arsenide substrates for AI datacom, defense, aerospace, automotive, and quantum applications. The company is early in commercialization and still generates most revenue from government research contracts.
Shares closed at $4.86, down $0.54, or 10.00%, from the prior session's close of $5.40. The direction was unambiguously lower, and the stock printed a new 52-week low of $4.80 during morning trade. No fresh company announcement, regulatory filing, or analyst action accompanied the move; the decline continues the repricing that followed the company's Nov. 12 fiscal first-quarter report.
The dominant narrative remains the fiscal Q1 2027 results. Revenue was $568,000 against $1.385 million a year earlier, a 59% decline driven by the company's deliberate shift away from legacy research work toward funded development programs. The GAAP net loss widened to $3.756 million, or $0.19 per share, from $1.493 million, or $0.09 per share, and adjusted EBITDA loss widened to $2.7 million from $0.45 million. Research and development expense more than quadrupled to $2.5 million.
Management said fiscal 2027 revenue will come from R&D contracts and commercial non-recurring engineering arrangements, with roughly $2.3 million expected from government contracts—about half of fiscal 2026's total—and no formal full-year outlook issued. For a company valued largely on a future AI-datacom ramp anticipated for fiscal 2028 and beyond, the absence of near-term revenue visibility leaves little to anchor valuation, and sellers have controlled the tape for six consecutive weeks.
The week after earnings, Craig-Hallum cut its price target to $13 from $22 while maintaining a Buy rating, citing added datacom customer discussions and the pending $30 million letter of intent with the U.S. Department of Commerce CHIPS R&D Office. Even after a 41% reduction, that target sits far above the current quote—a signal that the sell-side still models a successful commercialization timeline while the market discounts execution risk and further dilution. Consensus coverage is thin, with only a handful of analysts active, so a single revision carries outsized weight in sentiment.
Insider activity has leaned one way: roughly 15 open-market sales and no purchases over the past six months, including sizable sales by the chief executive. The company has also funded itself through at-the-market issuance—830,484 shares at an average of $24.87 in fiscal Q4—lifting shares outstanding to about 19.4 million. The balance sheet is genuinely strong, with $53.9 million in cash, no debt, and book value of $2.84 per share, but investors are increasingly focused on the pace of cash consumption rather than the cushion itself.
No verified news or fundamental catalyst found in today's session explains a 10% decline on its own. The action is instead consistent with a technical breakdown in a thinly traded micro-cap. Shares sit far beneath the 50-day moving average near $9.71 and the 200-day average near $15.89, both of which are declining, and the 14-day relative strength index had already fallen to roughly 29 before Friday—an oversold reading that has done nothing to arrest the slide. With the prior 52-week low at $5.34 cleared decisively, stop-loss and momentum-driven selling likely met a thin bid, a pattern typical of speculative micro-caps where small order flow moves price disproportionately.
Participation has thinned as the stock has fallen: the prior three sessions traded roughly 267,000 to 290,000 shares each, well below the three-month average near 650,000, and early Friday turnover was similarly light. Volume has not confirmed capitulation, which is one reason rallies have failed to hold. The move was company-specific in magnitude rather than a mirror of the broader tape; small-cap semiconductor and AI-photonics names have been volatile but not down double digits. Technically, the break below the November low voided the last visible support shelf, leaving the $4.50–$5.00 zone as the only nearby reference.
The score runs from 0, meaning no meaningful news and a routine move for the stock, to 100, meaning transformative news and an extreme, rare price move. Aeluma scores 25 out of 100.
The verified news is moderate rather than transformative: a revenue decline of 59%, a widening loss, no formal outlook, and a substantial analyst target cut—material for a company of this size, but a week old and already reflected in prior sessions. The price move was about 2.2 times the stock's average absolute daily change of 4.5% over the past 60 sessions, and seven sessions in that window produced moves of 10% or more, which caps the anomaly component. Strong balance sheet, weak momentum, ordinary volatility for this name: hence a modest score.
Fiscal second-quarter 2027 results are expected in early February 2027, and investors will want evidence that non-recurring engineering negotiations convert into signed agreements and recognized revenue. Near-term attention centers on the definitive CHIPS R&D agreement, the commissioning timeline for the newly purchased AIXTRON 200 mm-capable MOCVD system, and any datacom design wins tied to 2028-era AI infrastructure buildouts. Analyst expectations remain wide, with targets spanning roughly $13 to $25. Risks include continued cash burn against a sub-$1 million quarterly revenue base, potential further equity issuance, competitive pressure from established indium phosphide suppliers, customer concentration, and the possibility that commercialization slips again—each capable of driving further volatility in a stock that has lost roughly two-thirds of its value this year.
Tickeron's Trending AI Robots page curates the automated strategies performing strongest under present market conditions. Tickeron maintains hundreds of AI trading bots spanning thousands of tickers, but only a select group earns placement in this section. Bots differ widely by strategy logic, holding period, performance metrics, and the symbols they trade, so the roster shifts as conditions change. Reviewing the current leaders is a practical way to compare approaches against your own research process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ALMU saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In 76 of the 81 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ALMU turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 33 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALMU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ALMU entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +24.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALMU advanced for three days, in 113 of 137 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ALMU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.365) is normal, around the industry mean (5.443). P/E Ratio (-13.442) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. ALMU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALMU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors